ALB and Stroke: Our study successfully develops a novel predictive model for CMBs by integrating diverse clinical and laboratory parameters, including the Neutrophil to HDL Ratio, Albumin/Globulin ratio, gender, hypertension, homocysteine levels, and history of stroke.